
USA - NASDAQ:GHDX -
63.44
-0.44 (-0.69%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.36 | ||
| Fwd PE | 36.88 | ||
| P/S | 5.4 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 6.83 | ||
| P/tB | N/A | ||
| EV/EBITDA | 31.5 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.29% | ||
| ROE | 16.2% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 12.56% | ||
| PM (TTM) | 12.81% | ||
| GM | N/A | ||
| FCFM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.96 | ||
| Quick Ratio | 5.96 | ||
| Altman-Z | 14.43 |
ChartMill assigns a fundamental rating of 5 / 10 to GHDX.
ChartMill assigns a valuation rating of 0 / 10 to GENOMIC HEALTH INC (GHDX). This can be considered as Overvalued.
GENOMIC HEALTH INC (GHDX) has a profitability rating of 6 / 10.
The Earnings per Share (EPS) of GENOMIC HEALTH INC (GHDX) is expected to grow by 50.48% in the next year.
The dividend rating of GENOMIC HEALTH INC (GHDX) is 0 / 10 and the dividend payout ratio is 0%.